2430 related articles for article (PubMed ID: 23146760)
1. Resveratrol inhibits TGF-β1-induced epithelial-to-mesenchymal transition and suppresses lung cancer invasion and metastasis.
Wang H; Zhang H; Tang L; Chen H; Wu C; Zhao M; Yang Y; Chen X; Liu G
Toxicology; 2013 Jan; 303():139-46. PubMed ID: 23146760
[TBL] [Abstract][Full Text] [Related]
2. Resveratrol suppresses epithelial-to-mesenchymal transition in colorectal cancer through TGF-β1/Smads signaling pathway mediated Snail/E-cadherin expression.
Ji Q; Liu X; Han Z; Zhou L; Sui H; Yan L; Jiang H; Ren J; Cai J; Li Q
BMC Cancer; 2015 Mar; 15():97. PubMed ID: 25884904
[TBL] [Abstract][Full Text] [Related]
3. Stereospecific effects of ginsenoside 20-Rg3 inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses lung cancer migration, invasion and anoikis resistance.
Kim YJ; Choi WI; Jeon BN; Choi KC; Kim K; Kim TJ; Ham J; Jang HJ; Kang KS; Ko H
Toxicology; 2014 Aug; 322():23-33. PubMed ID: 24793912
[TBL] [Abstract][Full Text] [Related]
4. Geraniin inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration, invasion and anoikis resistance.
Ko H
Bioorg Med Chem Lett; 2015 Sep; 25(17):3529-34. PubMed ID: 26169124
[TBL] [Abstract][Full Text] [Related]
5. Sanguiin H6 suppresses TGF-β induction of the epithelial-mesenchymal transition and inhibits migration and invasion in A549 lung cancer.
Ko H; Jeon H; Lee D; Choi HK; Kang KS; Choi KC
Bioorg Med Chem Lett; 2015 Dec; 25(23):5508-13. PubMed ID: 26508552
[TBL] [Abstract][Full Text] [Related]
6. Dioscin suppresses TGF-β1-induced epithelial-mesenchymal transition and suppresses A549 lung cancer migration and invasion.
Lim WC; Kim H; Kim YJ; Choi KC; Lee IH; Lee KH; Kim MK; Ko H
Bioorg Med Chem Lett; 2017 Aug; 27(15):3342-3348. PubMed ID: 28610976
[TBL] [Abstract][Full Text] [Related]
7. Celecoxib and sulindac inhibit TGF-β1-induced epithelial-mesenchymal transition and suppress lung cancer migration and invasion via downregulation of sirtuin 1.
Cha BK; Kim YS; Hwang KE; Cho KH; Oh SH; Kim BR; Jun HY; Yoon KH; Jeong ET; Kim HR
Oncotarget; 2016 Aug; 7(35):57213-57227. PubMed ID: 27528025
[TBL] [Abstract][Full Text] [Related]
8. nm23-H1 is a negative regulator of TGF-β1-dependent induction of epithelial-mesenchymal transition.
Zhao R; Gong L; Li L; Guo L; Zhu D; Wu Z; Zhou Q
Exp Cell Res; 2013 Mar; 319(5):740-9. PubMed ID: 23137649
[TBL] [Abstract][Full Text] [Related]
9. Chimaphilin inhibits human osteosarcoma cell invasion and metastasis through suppressing the TGF-β1-induced epithelial-to-mesenchymal transition markers via PI-3K/Akt, ERK1/2, and Smad signaling pathways.
Dong F; Liu T; Jin H; Wang W
Can J Physiol Pharmacol; 2018 Jan; 96(1):1-7. PubMed ID: 28177668
[TBL] [Abstract][Full Text] [Related]
10. EGCG inhibits transforming growth factor-β-mediated epithelial-to-mesenchymal transition via the inhibition of Smad2 and Erk1/2 signaling pathways in nonsmall cell lung cancer cells.
Liu LC; Tsao TC; Hsu SR; Wang HC; Tsai TC; Kao JY; Way TD
J Agric Food Chem; 2012 Oct; 60(39):9863-73. PubMed ID: 22957988
[TBL] [Abstract][Full Text] [Related]
11. Nobiletin inhibits epithelial-mesenchymal transition of human non-small cell lung cancer cells by antagonizing the TGF-β1/Smad3 signaling pathway.
Da C; Liu Y; Zhan Y; Liu K; Wang R
Oncol Rep; 2016 May; 35(5):2767-74. PubMed ID: 26986176
[TBL] [Abstract][Full Text] [Related]
12. TGF-β1-induced epithelial-mesenchymal transition and acetylation of Smad2 and Smad3 are negatively regulated by EGCG in human A549 lung cancer cells.
Ko H; So Y; Jeon H; Jeong MH; Choi HK; Ryu SH; Lee SW; Yoon HG; Choi KC
Cancer Lett; 2013 Jul; 335(1):205-13. PubMed ID: 23419524
[TBL] [Abstract][Full Text] [Related]
13. Hypaconitine inhibits TGF-β1-induced epithelial-mesenchymal transition and suppresses adhesion, migration, and invasion of lung cancer A549 cells.
Feng HT; Zhao WW; Lu JJ; Wang YT; Chen XP
Chin J Nat Med; 2017 Jun; 15(6):427-435. PubMed ID: 28629532
[TBL] [Abstract][Full Text] [Related]
14. Interaction of hnRNP K with MAP 1B-LC1 promotes TGF-β1-mediated epithelial to mesenchymal transition in lung cancer cells.
Li L; Yan S; Zhang H; Zhang M; Huang G; Chen M
BMC Cancer; 2019 Sep; 19(1):894. PubMed ID: 31492158
[TBL] [Abstract][Full Text] [Related]
15. Resolvin D1 inhibits TGF-β1-induced epithelial mesenchymal transition of A549 lung cancer cells via lipoxin A4 receptor/formyl peptide receptor 2 and GPR32.
Lee HJ; Park MK; Lee EJ; Lee CH
Int J Biochem Cell Biol; 2013 Dec; 45(12):2801-7. PubMed ID: 24120851
[TBL] [Abstract][Full Text] [Related]
16. Cinnamomum cassia extracts reverses TGF-β1-induced epithelial-mesenchymal transition in human lung adenocarcinoma cells and suppresses tumor growth in vivo.
Lin CY; Hsieh YH; Yang SF; Chu SC; Chen PN; Hsieh YS
Environ Toxicol; 2017 Jul; 32(7):1878-1887. PubMed ID: 28258635
[TBL] [Abstract][Full Text] [Related]
17. SPOCK1 is a novel transforming growth factor-β target gene that regulates lung cancer cell epithelial-mesenchymal transition.
Miao L; Wang Y; Xia H; Yao C; Cai H; Song Y
Biochem Biophys Res Commun; 2013 Nov; 440(4):792-7. PubMed ID: 24134845
[TBL] [Abstract][Full Text] [Related]
18. Combined treatment with zingerone and its novel derivative synergistically inhibits TGF-β1 induced epithelial-mesenchymal transition, migration and invasion of human hepatocellular carcinoma cells.
Kim YJ; Jeon Y; Kim T; Lim WC; Ham J; Park YN; Kim TJ; Ko H
Bioorg Med Chem Lett; 2017 Feb; 27(4):1081-1088. PubMed ID: 28110870
[TBL] [Abstract][Full Text] [Related]
19. Kaempferol Suppresses Transforming Growth Factor-β1-Induced Epithelial-to-Mesenchymal Transition and Migration of A549 Lung Cancer Cells by Inhibiting Akt1-Mediated Phosphorylation of Smad3 at Threonine-179.
Jo E; Park SJ; Choi YS; Jeon WK; Kim BC
Neoplasia; 2015 Jul; 17(7):525-37. PubMed ID: 26297431
[TBL] [Abstract][Full Text] [Related]
20. Baicalin inhibits human osteosarcoma cells invasion, metastasis, and anoikis resistance by suppressing the transforming growth factor-β1-induced epithelial-to-mesenchymal transition.
Wang Y; Wang H; Zhou R; Zhong W; Lu S; Ma Z; Chai Y
Anticancer Drugs; 2017 Jul; 28(6):581-587. PubMed ID: 28379900
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
